Market Overview:
The global human tinea pedis drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of tinea pedis, rising awareness about available treatment options, and growing demand for topical antifungal drugs. The global human tinea pedis drugs market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into creams, sprays, and others. The creams segment is expected to account for a major share of the global human tinea pedis drugs market in 2018 owing to their high efficacy and ease of use. On the basis of application, the market is divided into offline store and online store segments. The offline store segment accounted for a major share of the global human tinea pedis drugs market in 2017 due to higher adoption rates in developing countries.
Product Definition:
Human Tinea Pedis Drugs is a drug used to treat tinea pedis, a fungal infection of the feet. It is important because it can help clear up the infection and prevent it from spreading.
Cream:
Cream is a topical anti-fungal medication used for the treatment of athlete's foot, ringworm, and jock itch. It works by killing the fungi that causes infection. Creams are available in various forms such as creams, lotions, gels and sprays.
Spray:
Spray is a topical solution that is applied to the skin for treating foot and ankle-related infections. It helps in reducing pain, itching, and inflammation of the skin as well as improves blood circulation in feet. The active ingredient present in spray helps to fight against fungi, bacteria, and viruses that cause tinea pedis (foot-related infection).
Application Insights:
The offline store was the dominant application segment in the global human tinea pedis drugs market, accounting for over 70% of the revenue share in 2017. TheOffline store is a retail establishment that stocks medicines and medical supplies. This type of store caters to people who cannot travel far from their homes due to physical disability or illness. These stores are present near hospitals and clinics where patients get access to various types of foot care treatments including medication, surgeries, diagnosis & treatment services for human tinea pedis at a reasonable cost as compared to other costs incurred while getting these services done at clinics or hospitals.
Online stores on the other hand cater more towards convenience than accessibility; customers living in remote areas with no presence of offline drugstores can easily order medicine through online stores owing to their 24*7 availability throughout the year along with easy payment options such as net banking.
Regional Analysis:
North America dominated the global human tinea pedis drugs market in 2017. The presence of key players, favorable reimbursement policies, and high adoption rate for new treatment options are some factors responsible for its large share. In addition, increasing prevalence of nail disorders is also expected to drive growth during the forecast period. For instance, according to a study published in JAMA Dermatology by American Academy of Dermatology (AAD), around 50 million people suffer from fungal infections each year in U.S.
Asia Pacific is estimated to be fastest growing region during the forecast period owing to rising disposable income coupled with growing awareness about early diagnosis among patients especially in developing countries such as India and China; hence driving demand for effective treatment methods leading towards growth opportunity for human tineae-pedis drugs market players over this region.
Growth Factors:
- Increasing incidence of tinea pedis owing to changing lifestyle and increasing population base.
- Growing awareness about the treatment and diagnosis of tinea pedis among people, especially in the developed countries.
- Rising demand for better-tolerated and more efficacious drugs for the treatment of tinea pedis, which is expected to drive market growth during the forecast period.
- Technological advancements in drug delivery systems that would offer more targeted therapies for tinea pedis are likely to propel market growth over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Tinea Pedis Drugs Market Research Report
By Type
Cream, Spray, Others
By Application
Offline Store, Online Store
By Companies
Bayer, GSK, Johnson & Johnson, Novartis, Bausch Health, TEVA, Taro Pharmaceutical, WellSpring Pharma, Crown Laboratories, Medimetriks Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
211
Number of Tables & Figures
148
Customization Available
Yes, the report can be customized as per your need.
Global Human Tinea Pedis Drugs Market Report Segments:
The global Human Tinea Pedis Drugs market is segmented on the basis of:
Types
Cream, Spray, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Offline Store, Online Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- GSK
- Johnson & Johnson
- Novartis
- Bausch Health
- TEVA
- Taro Pharmaceutical
- WellSpring Pharma
- Crown Laboratories
- Medimetriks Pharmaceuticals
Highlights of The Human Tinea Pedis Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cream
- Spray
- Others
- By Application:
- Offline Store
- Online Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Tinea Pedis Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There are a number of drugs used to treat human tinea pedis. These include topical creams, oral medications, and systemic antibiotics.
Some of the major companies in the human tinea pedis drugs market are Bayer, GSK, Johnson & Johnson, Novartis, Bausch Health, TEVA, Taro Pharmaceutical, WellSpring Pharma, Crown Laboratories, Medimetriks Pharmaceuticals.
The human tinea pedis drugs market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Human Tinea Pedis Drugs Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Human Tinea Pedis Drugs Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Human Tinea Pedis Drugs Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Human Tinea Pedis Drugs Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Human Tinea Pedis Drugs Market Size & Forecast, 2020-2028 4.5.1 Human Tinea Pedis Drugs Market Size and Y-o-Y Growth 4.5.2 Human Tinea Pedis Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Cream
5.2.2 Spray
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Offline Store
6.2.2 Online Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Human Tinea Pedis Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Human Tinea Pedis Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Cream
9.6.2 Spray
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Offline Store
9.10.2 Online Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Cream
10.6.2 Spray
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Offline Store
10.10.2 Online Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Cream
11.6.2 Spray
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Offline Store
11.10.2 Online Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Cream
12.6.2 Spray
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Offline Store
12.10.2 Online Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Cream
13.6.2 Spray
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Offline Store
13.10.2 Online Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Human Tinea Pedis Drugs Market: Competitive Dashboard
14.2 Global Human Tinea Pedis Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 GSK
14.3.3 Johnson & Johnson
14.3.4 Novartis
14.3.5 Bausch Health
14.3.6 TEVA
14.3.7 Taro Pharmaceutical
14.3.8 WellSpring Pharma
14.3.9 Crown Laboratories
14.3.10 Medimetriks Pharmaceuticals